Additionally, ribitol has been shown to enhance the cytotoxic effects of SHK by interfering with cancer cell metabolism and regulating apoptotic and oncogenic pathways, presenting a possible strategy for overcoming drug resistance and suppressing tumor growth (Doddapaneni et al., 2025). This evidence concerns the gene SHPK and neoplasm.